Adenoviruses began to be developed into highly effective gene expressi
on vectors in the early 1980s. Recently, the increased interest in uti
lizing this transfer system in vivo has posed new problems for heterol
ogous gene-transfer, spurring a renewed effort in the field of vector
development toward solving the structural, immunological and targeting
problems posed by gene therapy applications.